Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 301 | — | UPSTREAM BIO INC | — | 9,801.0 | $266K | 0.07% | NEW | — | $27.15 | — |
| 302 | NTLA | INTELLIA THERAPEUTICS INC | Healthcare | 29,493.0 | $265K | 0.07% | NEW | — | $8.99 | +40.3% |
| 303 | SMMT | SUMMIT THERAPEUTICS INC | Healthcare | 15,141.0 | $265K | 0.07% | NEW | — | $17.49 | -2.8% |
| 304 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 13,949.0 | $265K | 0.07% | NEW | — | $18.97 | -8.4% |
| 305 | — | INHIBRX BIOSCIENCES INC | — | 3,343.0 | $264K | 0.07% | NEW | — | $79.00 | — |
| 306 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 9,671.0 | $263K | 0.07% | NEW | — | $27.16 | +13.6% |
| 307 | NGNE | NEUROGENE INC | Healthcare | 12,716.0 | $262K | 0.07% | NEW | — | $20.60 | +31.6% |
| 308 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 7,209.0 | $262K | 0.07% | NEW | — | $36.29 | -17.4% |
| 309 | STOK | STOKE THERAPEUTICS INC | Healthcare | 8,214.0 | $261K | 0.07% | NEW | — | $31.74 | -2.2% |
| 310 | — | BIOHAVEN LTD | — | 23,072.0 | $260K | 0.07% | NEW | — | $11.29 | — |
| 311 | — | APOGEE THERAPEUTICS INC | — | 3,451.0 | $260K | 0.07% | NEW | — | $75.48 | — |
| 312 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 6,315.0 | $260K | 0.07% | NEW | — | $41.21 | +110.7% |
| 313 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 7,913.0 | $259K | 0.07% | NEW | — | $32.76 | +124.8% |
| 314 | GHRS | GH RESEARCH PLC | Healthcare | 20,408.0 | $259K | 0.07% | NEW | — | $12.70 | +82.3% |
| 315 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 8,233.0 | $256K | 0.07% | NEW | — | $31.12 | -45.4% |
| 316 | IMVT | IMMUNOVANT INC | Healthcare | 10,069.0 | $256K | 0.07% | NEW | — | $25.42 | +33.1% |
| 317 | SION | SIONNA THERAPEUTICS INC | Healthcare | 6,220.0 | $256K | 0.07% | NEW | — | $41.14 | +4.2% |
| 318 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 16,310.0 | $256K | 0.07% | NEW | — | $15.68 | +22.4% |
| 319 | NUVL | NUVALENT INC | Healthcare | 2,538.0 | $255K | 0.07% | NEW | — | $100.59 | +4.3% |
| 320 | REPL | REPLIMUNE GROUP INC | Healthcare | 26,133.0 | $254K | 0.07% | NEW | — | $9.72 | -52.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
25.9%
Financial Services
25.7%
Technology
17.4%
Industrials
10.0%
Consumer Cyclical
7.5%
Communication Services
4.3%
Energy
2.6%
Real Estate
2.5%
Consumer Defensive
1.8%
Basic Materials
1.5%